XML 38 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Jun. 30, 2014
Dec. 31, 2013
Current assets:    
Cash and cash equivalents $ 14,537 $ 11,639
Short-term investments 7,490 4,340
Accounts receivable 3,133 2,222
Inventory 817 1,392
Capitalized IPO expenses, Viking Therapeutics, Inc. 1,094 0
Other current assets 1,123 959
Current portion of co-promote termination payments receivable 391 4,329
Total current assets 28,585 24,881
Restricted cash and investments 1,261 1,341
Property and equipment, net 619 867
Intangible assets, net 51,911 53,099
Goodwill 12,238 12,238
Commercial license rights 4,567 4,571
Long-term portion of co-promote termination payments receivable 413 7,417
Other assets 253 299
Total assets 99,847 104,713
Current liabilities:    
Accounts payable (including $1.4 million related to a VIE, Viking Therapeutics, Inc.) 5,059 3,951
Accrued liabilities 3,241 5,337
Current portion of contingent liabilities 2,877 1,712
Current portion of deferred income taxes 1,574 1,574
Current portion of note payable 2,698 9,109
Current portion of co-promote termination liability 391 4,329
Current portion of lease exit obligations 2,689 2,811
Current portion of deferred revenue 92 116
Total current liabilities 18,621 28,939
Long-term portion of co-promote termination liability 413 7,417
Long-term portion of deferred revenue, net 2,085 2,085
Long-term portion of lease exit obligations 1,587 3,071
Deferred income taxes 1,104 1,098
Long-term portion of contingent liabilities 12,223 11,795
Other long-term liabilities 728 695
Total liabilities 36,761 55,100
Commitments and Contingencies      
Stockholders' equity:    
Common stock, $0.001 par value; 33,333,333 shares authorized; 20,778,526 and 20,468,521 shares issued and outstanding at June 30, 2014 and December 31, 2013, respectively 21 21
Additional paid-in capital 726,758 718,017
Accumulated other comprehensive income 5,041 2,914
Accumulated deficit (667,650) (671,339)
Total stockholders' equity attributable to parent 64,170 49,613
Noncontrolling interests (1,084) 0
Total liabilities and stockholders' equity $ 99,847 $ 104,713